Last reviewed · How we verify
Clobromsalan (bromochlorosalicylanilide)
Clobromsalan (generic name: bromochlorosalicylanilide) is a bromochlorosalicylanilide drug. It is currently in unknown development.
Clobromsalan is thought to work by interacting with cellular targets, although its exact mechanism of action is not well understood.
Clobromsalan, also known as bromochlorosalicylanilide, is an antifungal agent. It may cause allergic contact dermatitis in some individuals.
At a glance
| Generic name | bromochlorosalicylanilide |
|---|---|
| Drug class | bromochlorosalicylanilide |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells have locks on them, and Clobromsalan is a key that fits into one of those locks. When it binds to the lock, it can affect how the cell works, but we don't know exactly how it does that yet. More research is needed to understand how Clobromsalan interacts with cells and what effects it has on the body.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Clobromsalan CI brief — competitive landscape report
- Clobromsalan updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Clobromsalan
What is Clobromsalan?
How does Clobromsalan work?
What is the generic name of Clobromsalan?
What drug class is Clobromsalan in?
What development phase is Clobromsalan in?
Related
- Drug class: All bromochlorosalicylanilide drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing